Institutional members access full text with Ovid®

Share this article on:

Comparison of Initial Experiences of Robot-Assisted Radical Cystectomy With Those of Laparoscopic for Bladder Cancer

Teishima, Jun MD, PhD; Hieda, Keisuke MD; Inoue, Shogo MD; Goto, Keisuke MD; Ikeda, Kenichiro MD; Ohara, Shinya MD, PhD; Kobayashi, Kanao MD; Kajiwara, Mitsuru MD, PhD; Matsubara, Akio MD, PhD

Innovations:Technology and Techniques in Cardiothoracic and Vascular Surgery: July/August 2014 - Volume 9 - Issue 4 - p 322–326
doi: 10.1097/IMI.0000000000000056
Original Articles

Objective The aim of the present study was to evaluate perioperative outcomes in initial experiences of robot-assisted laparoscopic radical cystectomy (RARC) in comparison with those of laparoscopic radical cystectomy (LRC) for muscle-invasive or high-risk non–muscle-invasive bladder cancer.

Methods We performed RARC on six patients with muscle-invasive or high-risk non–muscle-invasive bladder cancer starting in October 2011. During the same period, another five patients underwent LRC. Perioperative outcomes in initial experiences of RARC were elucidated by comparing them with those of LRC.

Results Robot-assisted procedures were completed in all cases without conversion to open surgery. The median time of pneumoperitoneum was 252 minutes, and the median blood loss was 340 mL. No severe complications were observed. Perioperative outcomes did not significantly differ between RARC and LRC. Although two cases of troubles in uretero-conduit anastomosis sites were observed after LRC, no patients experienced postoperative complication related to urinary diversion after RARC.

Conclusions Our data indicate that RARC is an acceptable option even in the initial period, and it may become one of the most favorable procedures for treatment of muscle-invasive bladder cancer in the near future, although more tests and longer follow-ups are required to confirm its effectiveness and safety.

From the Department of Urology, Integrated Health Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.

Accepted for publication December 17, 2013.

Disclosure: The authors declare no conflicts of interest.

Address correspondence and reprint requests to Jun Teishima, MD, PhD, Department of Urology, Integrated Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima 734-8551, Japan. E-mail:

©2014 by the International Society for Minimally Invasive Cardiothoracic Surgery